natgillin/translations-raw huggingface dataset:
Such a failure could create legal uncertainty for the rail industry, the national authorities and the Agency as to the legislation that applies to rail safety and interoperability.
To bi lahko povzročilo pravno negotovost za železniško industrijo, nacionalne organe in Agencijo glede zakonodaje, ki se uporablja za varnost in interoperabilnost v železniškem prometu.
In order to allow for the prompt application of the measures provided for in this Directive, this Directive should enter into force as a matter of urgency on the day following that of its publication in the Official Journal of the European Union,
Da bi se omogočila takojšnja uporaba ukrepov iz te direktive, bi morala ta direktiva nujno začeti veljati dan po objavi v Uradnem listu Evropske unije -
In view of the current situation, those delegated acts need to be aligned with the new transposition deadline.
Glede na trenutne razmere je treba te delegirane akte uskladiti z novim rokom za prenos.
Due to the extraordinary and unforeseeable situation caused by the COVID‐19 outbreak, some of those Member States are having difficulties completing the legislative work within the given transposition deadlines and therefore risk failing to comply with them.
Zaradi izrednih in nepredvidljivih razmer, ki jih je povzročil izbruh COVID-19, imajo nekatere od teh držav članic težave pri dokončanju zakonodajnega dela v določenih rokih za prenos in zato tvegajo, da rokov ne bodo mogle spoštovati.
In view of the urgency entailed by the exceptional circumstances caused by the outbreak of COVID‐19, it was considered to be appropriate to provide for an exception to the eight‐week period referred to in Article 4 of Protocol No 1 on the role of national Parliaments in the European Union, annexed to the Treaty on European Union (TEU), to the Treaty on the Functioning of the European Union and to the Treaty establishing the European Atomic Energy Community.
Zaradi nujnosti, ki jo narekujejo izjemne okoliščine, ki jih je povzročil izbruh COVID-19, je bilo primerno določiti izjemo od roka osmih tednov iz člena 4 Protokola št. 1 o vlogi nacionalnih parlamentov v Evropski uniji, ki je priložen Pogodbi o Evropski uniji (PEU), Pogodbi o delovanju Evropske unije in Pogodbi o ustanovitvi Evropske skupnosti za atomsko energijo.
It is essential to provide legal clarity and certainty to the rail industry by allowing, where relevant, Member States to continue to apply, from 16 June 2020 and for a limited period, Directives 2004/49/EC (4) and 2008/57/EC (5) of the European Parliament and of the Council.
Bistveno je zagotoviti pravno jasnost in varnost v železniški industriji tako, da se državam članicam po potrebi omogoči, da od 16. junija 2020 za omejeno obdobje še naprej uporabljajo direktivi 2004/49/ES (4) in 2008/57/ES (5) Evropskega parlamenta in Sveta.
Since the objective of this Directive, namely to amend Directives (EU) 2016/797 and (EU) 2016/798 in view of the COVID‐19 outbreak, cannot be sufficiently achieved by the Member States but can rather, by reason of its scale or effects, be better achieved at Union level, the Union may adopt measures, in accordance with the principle of subsidiarity as set out in Article 5 of the TEU.
Ker cilja te direktive, in sicer spremembe direktiv (EU) 2016/797 in (EU) 2016/798, zaradi izbruha COVID-19 države članice ne morejo zadovoljivo doseči, temveč se zaradi njegovega obsega in učinkov lažje doseže na ravni Unije, lahko Unija sprejme ukrepe v skladu z načelom subsidiarnosti iz člena 5 PEU.
Seventeen Member States have notified the Commission and the European Union Agency for Railways (the ‘Agency') of an extension to the transposition deadlines of Directives (EU) 2016/797 and (EU) 2016/798 to 16 June 2020.
Sedemnajst držav članic je uradno obvestilo Komisijo in Agencijo Evropske unije za železnice (v nadaljnjem besedilu: Agencija) o podaljšanju rokov za prenos direktiv (EU) 2016/797 in (EU) 2016/798 na 16. junij 2020.
The inability of certain Member States to transpose Directives (EU) 2016/797 and (EU) 2016/798 as a result of the COVID‐19 outbreak has detrimental consequences for the rail sector.
Nezmožnost nekaterih držav članic, da prenesejo direktivi (EU) 2016/797 in (EU) 2016/798 zaradi izbruha COVID-19, ima škodljive posledice za železniški sektor.
In accordance with Article 57(1) of Directive (EU) 2016/797 of the European Parliament and of the Council (2) and Article 33(1) of Directive (EU) 2016/798 of the European Parliament and of the Council (3) , Member States were to have brought into force the laws, regulations and administrative provisions necessary for them to comply with the relevant provisions of those Directives by 16 June 2019.
V skladu s členom 57(1) Direktive (EU) 2016/797 Evropskega parlamenta in Sveta (2) ter členom 33(1) Direktive (EU) 2016/798 Evropskega parlamenta in Sveta (3) so morale države članice do 16. junija 2019 uveljaviti zakone in druge predpise, potrebne za njihovo uskladitev z zadevnimi določbami navedenih direktiv.
However, pursuant to Article 57(2) of Directive (EU) 2016/797 and Article 33(2) of Directive (EU) 2016/798, Member States had the possibility to extend the transposition period by one year.
Vendar so imele države članice v skladu s členom 57(2) Direktive (EU) 2016/797 in členom 33(2) Direktive (EU) 2016/798 možnost, da obdobje za prenos podaljšajo za eno leto.
Since the COVID‐19 outbreak occurred during the final stage of adoption of the national transposition measures of Directives (EU) 2016/797 and (EU) 2016/798, Member States should be allowed an additional period to complete the transposition process.
Ker je do izbruha COVID-19 prišlo med zadnjo fazo sprejemanja nacionalnih ukrepov za prenos direktiv (EU) 2016/797 in (EU) 2016/798, bi bilo treba državam članicam omogočiti dodatno obdobje za dokončanje postopka prenosa.
The repeal dates of Directives 2004/49/EC and 2008/57/EC, as set out in Article 58 of Directive (EU) 2016/797 and Article 34 of Directive (EU) 2016/798 respectively, should be adjusted accordingly.
Datuma za razveljavitev direktiv 2004/49/ES in 2008/57/ES, kot sta določena v členu 58 Direktive (EU) 2016/797 oziroma členu 34 Direktive (EU) 2016/798, bi bilo treba ustrezno prilagoditi.
A number of delegated acts have been adopted on the basis of Directive (EU) 2016/798 reflecting previous transposition deadlines.
Na podlagi Direktive (EU) 2016/798 je bilo sprejetih več delegiranih aktov, ki odražajo prejšnje roke za prenos.
amending Directives (EU) 2016/797 and (EU) 2016/798, as regards the extension of their transposition periods
o spremembi direktiv (EU) 2016/797 in (EU) 2016/798 glede podaljšanja obdobij za njun prenos
The transposition deadlines of Directives (EU) 2016/797 and (EU) 2016/798 should be extended until 31 October 2020.
Roka za prenos direktiv (EU) 2016/797 in (EU) 2016/798 bi bilo treba podaljšati do 31. oktobra 2020.
Directives (EU) 2016/797 and (EU) 2016/798 should therefore be amended accordingly.
Direktivi (EU) 2016/797 in (EU) 2016/798 bi bilo zato treba ustrezno spremeniti.
of 3 June 2020
z dne 3. junija 2020
HAS ADOPTED THIS DIRECTIVE:
SPREJELA NASLEDNJO DIREKTIVO:
While there is no vaccine or effective treatment currently available, considerable efforts are being deployed internationally and a significant number of vaccine candidates have so far been identified.
Čeprav trenutno ni na voljo cepiva ali učinkovitega zdravljenja, na mednarodni ravni potekajo znatna prizadevanja in doslej je bilo določenih precej kandidatov za cepivo.
Based on a wide consultation, a transposition period of 5 months was considered to be appropriate.
Z obsežnim posvetovanjem je bilo ocenjeno, da je ustrezno obdobje za prenos pet mesecev.
On this basis, the Commission would review, if necessary, the risk group classification as established through the adoption of this Directive.
Na podlagi tega bi Komisija po potrebi pregledala razvrstitev v rizično skupino, kot je določena s sprejetjem te direktive.
In preparing this Directive, the Commission was assisted by experts representing Member States, who provided technical and scientific support.
Pri pripravi te direktive so Komisiji pomagali strokovnjaki, ki so kot zastopniki držav članic zagotavljali tehnično in znanstveno podporo.
In the light of the exceptional circumstances, Member States are encouraged to implement this Directive before the deadline for transposition, where possible.
Glede na izjemne okoliščine se države članice spodbuja k izvajanju te direktive pred rokom za prenos, kadar je to mogoče.
The measures provided for in this Directive are in accordance with the opinion of the committee established by Article 17 of Council Directive 89/391/EEC (6) ,
Ukrepi iz te direktive so v skladu z mnenjem odbora, ustanovljenega v skladu s členom 17 Direktive Sveta 89/391/EGS (6) -
The Union strives to maintain its high standards for ensuring adequate protection of workers' health, which is particularly relevant in the context of a global health pandemic.
Unija si prizadeva ohraniti visoke standarde ustreznega varovanja zdravja delavcev, kar je zlasti pomembno v kontekstu svetovne zdravstvene pandemije.
In accordance with the Joint Political Declaration of 28 September 2011 of Member States and the Commission on explanatory documents (5) , Member States have undertaken to accompany, in justified cases, the notification of their transposition measures with one or more documents explaining the relationship between the components of a directive and the corresponding parts of national transposition instruments.
V skladu s Skupnimi političnimi izjavami z dne 28. septembra 2011 držav članic in Komisije o obrazložitvenih dokumentih (5) se države članice zavezujejo, da bodo v upravičenih primerih obvestilu o ukrepih za prenos priložile enega ali več dokumentov, ki pojasnjujejo razmerje med elementi direktive in ustreznimi deli nacionalnih instrumentov za prenos.
More than ever, strict compliance with and application of national provisions transposing Union rules on safety and health at work are of utmost importance.
Bolj kot kdaj prej je pomembno dosledno spoštovati in uporabljati nacionalne določbe, ki prenašajo pravila Unije o varnosti in zdravju pri delu.
The outbreak of COVID-19, a new coronavirus disease, has affected all Member States since early 2020 and is causing major disruptions to all sectors and services, directly impacting the health and safety of all workers across the Union.
Izbruh nove koronavirusne bolezni COVID-19 je od začetka leta 2020 prizadel vse države članice in povzroča velike motnje za vse sektorje in storitve, kar neposredno vpliva na zdravje in varnost vseh delavcev v Uniji.
In the light of the severity of the global COVID-19 pandemic and taking into consideration that every worker has the right to a healthy, safe and well-adapted working environment, as provided by Principle 10 of the European Pillar of Social Rights (4) , this Directive should provide for a short transposition period.
Glede na resnost svetovne pandemije COVID-19 in ob upoštevanju dejstva, da ima vsak delavec pravico do zdravega, varnega in dobro prilagojenega delovnega okolja, kot je določeno v načelu 10 evropskega stebra socialnih pravic (4) , bi bilo treba v tej direktivi določiti kratko obdobje za prenos.
In line with introductory note 6 in that Annex, that list should be amended to take into account the latest knowledge as regards scientific and epidemiological development that have brought about significant changes, including the existence of new biological agents.
V skladu z uvodno pripombo 6 iz navedene priloge bi bilo treba ta seznam spremeniti, da bi se upoštevala najnovejša spoznanja v zvezi z znanstvenim in epidemiološkim razvojem, ki je privedel do pomembnih sprememb, vključno z obstojem novih bioloških dejavnikov.
To ensure sufficient capacity as well as continuity of the vital work carried out by diagnostic laboratories across the Union, this should be made clear in Annex III to Directive 2000/54/EC.
Za zagotovitev zadostne zmogljivosti in kontinuitete življenjsko pomembnega dela, ki ga izvajajo diagnostični laboratoriji po vsej Uniji, bi bilo to treba pojasniti v Prilogi III k Direktivi 2000/54/ES.
Several Member States, as well as EFTA States and other third countries, have started taking measures regarding the classification of SARS-CoV-2 in risk group 3.
Več držav članic, pa tudi držav Efte in drugih tretjih držav je začelo sprejemati ukrepe v zvezi z razvrstitvijo SARS-CoV-2 v rizično skupino 3.
The Commission will continue to closely monitor the situation regarding the COVID-19 outbreak, including the development of a possible vaccine and the availability of further technological and scientific data and evidence concerning SARS-COV-2.
Komisija bo še naprej pozorno spremljala razmere v zvezi z izbruhom COVID-19, vključno z razvojem cepiva ter razpoložljivostjo nadaljnjih tehnoloških in znanstvenih podatkov in dokazov glede SARS-CoV-2.
In March 2020, the World Health Organization published biosafety guidance for laboratories concerning the new coronavirus and the testing of clinical specimens of patients infected with SARS-CoV-2 (3) .
Svetovna zdravstvena organizacija je marca 2020 objavila smernice o biološki varnosti za laboratorije v zvezi z novim koronavirusom in testiranjem kliničnih vzorcev pacientov, okuženih s SARS-CoV-2 (3) .
SARS-CoV-2 can cause severe human disease among the infected population, presenting in particular a serious hazard to elderly workers and those with an underlying medical problem or chronic disease.
SARS-CoV-2 lahko povzroči hudo bolezen ljudi pri okuženi populaciji in pomeni resno nevarnost zlasti za starejše delavce in osebe z obstoječimi zdravstvenimi težavami ali kronično boleznijo.
Moreover, the tripartite Advisory Committee for Safety and Health at Work was consulted concerning the purely technical adjustments to Directive 2000/54/EC in the context of the SARS-CoV-2 outbreak.
Poleg tega je bilo opravljeno posvetovanje s tristranskim Svetovalnim odborom za varnost in zdravje pri delu glede izključno tehničnih prilagoditev Direktive 2000/54/ES v povezavi z izbruhom SARS-CoV-2.
Consideration was given to the need to maintain the existing levels of protection for workers who are exposed, or are potentially exposed, to biological agents through their work, and to ensure that the amendments only take into account scientific developments in the area, requiring adjustments at the workplace that are merely technical in nature.
Upoštevala se je potreba po ohranitvi obstoječih ravni varovanja delavcev, ki so pri delu izpostavljeni ali potencialno izpostavljeni biološkim dejavnikom, ter zagotavljanju, da se pri spremembah upošteva le znanstveni razvoj na tem področju, pri čemer so na delovnem mestu potrebne zgolj tehnične prilagoditve.
Directive 2000/54/EC lays down rules to protect workers against risks to their health and safety, including the prevention of such risks, arising or likely to arise from exposure to biological agents at work.
Direktiva 2000/54/ES določa pravila za varovanje delavcev pred tveganji za njihovo zdravje in varnost, vključno s preprečevanjem takih tveganj, ki izhajajo ali bi lahko izhajala iz izpostavljenosti biološkim dejavnikom pri delu.
Considering the epidemiological and clinical data currently available concerning the virus' characteristics such as its transmission patterns, clinical features and risk factors for infection, SARS-CoV-2 should be added to Annex III to Directive 2000/54/EC as a matter of urgency, to ensure the continued adequate protection of workers' health and safety at work.
Glede na epidemiološke in klinične podatke, ki so trenutno na voljo v zvezi z značilnostmi virusa, kot so vzorci njegovega prenosa, klinični znaki in dejavniki tveganja za okužbo, bi bilo treba SARS-CoV-2 nujno dodati v Prilogo III k Direktivi 2000/54/ES, da se zagotovi stalno ustrezno varovanje zdravja in varnosti delavcev pri delu.
The virus ‘severe acute respiratory syndrome coronavirus 2' or, in short, ‘SARS-CoV-2', which caused the outbreak of COVID-19, shows great similarities with the SARS-virus and the MERS-virus.
Virus „koronavirus 2 hudega akutnega respiratornega sindroma" ali kratko „SARS-CoV-2", ki je povzročil izbruh COVID-19, kaže velike podobnosti z virusom SARS in virusom MERS.
Having regard to Directive 2000/54/EC of the European Parliament and of the Council of 18 September 2000 on the protection of workers from risks related to exposure to biological agents at work (1) , and in particular Article 19 thereof,
ob upoštevanju Direktive Evropskega parlamenta in Sveta 2000/54/ES z dne 18. septembra 2000 o varovanju delavcev pred tveganji zaradi izpostavljenosti biološkim dejavnikom pri delu (1) in zlasti člena 19 Direktive,
The guidance specifies that non-propagative diagnostic laboratory work, such as sequencing, can be conducted at a facility using procedures equivalent to at least containment level 2 (Biosafety Level 2, BSL-2), while propagative work involving SARS-CoV-2 should be conducted at a containment laboratory with air pressure negative to atmosphere (Biosafety Level 3, BSL-3).
Smernice določajo, da se diagnostično laboratorijsko delo, ki ne vključuje razmnoževanja, kot je sekvenciranje, lahko izvaja v objektu, kjer se uporabljajo postopki, enakovredni najmanj osamitveni stopnji 2 (stopnja biološke varnosti 2, BSL-2), medtem ko bi se moralo delo, ki vključuje razmnoževanje SARS-CoV-2, izvajati v osamitvenem laboratoriju z zračnim tlakom, nižjim od atmosferskega (stopnja biološke varnosti 3, BSL-3).
Taking into account the latest scientific evidence and clinical data available as well as advice provided by experts representing all Member States, SARS-CoV-2 should therefore be classified as a risk group 3 human pathogen.
Na podlagi najnovejših razpoložljivih znanstvenih dokazov in kliničnih podatkov ter nasvetov strokovnjakov, ki zastopajo vse države članice, bi bilo treba SARS-CoV-2 razvrstiti kot človeški patogen iz rizične skupine 3.
It applies to activities in which workers are exposed, or are potentially exposed, to biological agents as a result of their work, and states the measures to be taken in the case of any activity likely to involve a risk of exposure to biological agents, to determine the nature, degree and duration of workers' exposure to such agents.
Direktiva se uporablja za dejavnosti, pri katerih so delavci zaradi svojega dela izpostavljeni ali potencialno izpostavljeni biološkim dejavnikom, in navaja ukrepe, ki jih je treba sprejeti v primeru kakršne koli dejavnosti, ki lahko vključuje tveganje izpostavljenosti biološkim dejavnikom, da se določi narava, stopnja in trajanje izpostavljenosti delavcev takim dejavnikom.
amending Annex III to Directive 2000/54/EC of the European Parliament and of the Council as regards the inclusion of SARS-CoV-2 in the list of biological agents known to infect humans and amending Commission Directive (EU) 2019/1833
o spremembi Priloge III k Direktivi Evropskega parlamenta in Sveta 2000/54/ES glede vključitve SARS-CoV-2 na seznam bioloških dejavnikov, za katere je znano, da okužijo ljudi, in spremembi Direktive Komisije (EU) 2019/1833
Annex III to Directive 2000/54/EC sets out the list of biological agents known to infect humans, classified according to their level of risk of infection.
Priloga III k Direktivi 2000/54/ES določa seznam bioloških dejavnikov, razvrščenih glede na stopnjo tveganja okužbe, za katere je znano, da okužijo ljudi.
Directive (EU) 2019/1833 also amended Annex V and Annex VI to Directive 2000/54/EC, which lay down containment measures and levels for laboratories, animal facilities and industry.
Z Direktivo (EU) 2019/1833 sta bili spremenjeni tudi prilogi V in VI k Direktivi 2000/54/ES, ki določata osamitvene ukrepe in stopnje za laboratorije, objekte za živali ter industrijo.
To provide workers with the appropriate levels of protection, the date for transposition of the amendments to those Annexes as regards exposure to SARS-CoV-2 should also be brought forward.
Da se delavcem zagotovi ustrezna raven varovanja, bi bilo treba prenos sprememb navedenih prilog glede izpostavljenosti SARS-CoV-2 prav tako prestaviti na zgodnejši datum.
In October 2019, Commission Directive (EU) 2019/1833 (2) amended Annex III to Directive 2000/54/EC, which resulted notably in the addition of a large number of biological agents, including the Severe Acute Respiratory Syndrome-related coronavirus (SARS-virus) and the Middle East Respiratory Syndrome coronavirus (MERS-virus).
Oktobra 2019 je bila z Direktivo Komisije (EU) 2019/1833 (2) spremenjena Priloga III k Direktivi 2000/54/ES, kar je omogočilo vključitev velikega števila bioloških dejavnikov, vključno s koronavirusom, povezanim s sindromom akutne respiratorne stiske (virus SARS), in koronavirusom bližnjevzhodnega respiratornega sindroma (virus MERS).
HAS ADOPTED THIS GUIDELINE:
SPREJEL NASLEDNJO SMERNICO:
To react promptly to the current pandemic situation, this Guideline should be notified to the NCBs as soon as possible after adoption.
Da bi se hitro odzvali na sedanje razmere pandemije, bi morali o tej smernici čim prej po sprejetju uradno obvestiti NCB.
Therefore Guideline ECB/2014/31 (4) should be amended accordingly,
Zato je treba Smernico ECB/2014/31 (4) ustrezno spremeniti -
The additional measures set out in the amendments introduced under this Guideline should apply temporarily and the Governing Council should re-assess the need for extending any of these temporary measures before the end of the year to ensure an appropriate monetary policy transmission mechanism.
Dodatni ukrepi, določeni v spremembah, uvedenih v skladu s to smernico, bi se morali uporabljati začasno, Svet ECB pa bi moral še pred koncem leta ponovno oceniti potrebo po podaljšanju katerega koli od teh začasnih ukrepov, da se zagotovi ustrezen transmisijski mehanizem denarne politike.
Accordingly, participation in these operations will be based on amended collateral eligibility criteria and risk control measures.
Skladno s tem bo sodelovanje pri teh operacijah temeljilo na spremenjenih kriterijih primernosti zavarovanja in ukrepih za obvladovanje tveganj.
On 7 April 2020, the Governing Council adopted a set of decisions in response to the coronavirus pandemic, which could jeopardise the objective of price stability and the proper functioning of the monetary policy transmission mechanism.
Svet ECB je 7. aprila 2020 sprejel sklop odločitev v odziv na pandemijo koronavirusa, ki bi lahko ogrozila cilj stabilnosti cen in pravilno delovanje transmisijskega mehanizma denarne politike.
amending Guideline ECB/2014/31 on additional temporary measures relating to Eurosystem refinancing operations and eligibility of collateral (ECB/2020/21)
o spremembi Smernice ECB/2014/31 o dodatnih začasnih ukrepih v zvezi z Eurosistemovimi operacijami refinanciranja in primernostjo zavarovanja (ECB/2020/21)
In doing so, the Governing Council will also take into account the need of Eurosystem counterparties that are, or will be, participating in targeted longer-term refinancing operations conducted under Decision (EU) 2019/1311 of the European Central Bank (ECB/2019/21) (3) to maintain collateral availability for the entire duration of these operations.
Svet ECB bo pri tem upošteval tudi potrebo nasprotnih strank Eurosistema, ki sodelujejo ali bodo sodelovale v ciljno usmerjenih operacijah dolgoročnejšega refinanciranja, ki se izvajajo v skladu s Sklepom Evropske centralne banke (EU) 2019/1311 (ECB/2019/21) (3) , da ohranijo razpoložljivost zavarovanja za celotno trajanje teh operacij.